Our Bureaus The stage is set for the technical review of Bharat Biotech’s Covaxin, with the World Health Organization’s policy expert group completing its evaluation of the Covid vaccine.
Giving details of the review meeting last week by the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunisation, the agency said: “Bharat Biotech’s Covid vaccine (Covaxin) was reviewed by SAGE; a policy recommendation will be issued when the vaccine is Emergency Use listed by WHO.”
Representatives clarified that SAGE and the Technical Advisory Group (TAG) evaluate the same evidence on the vaccine, but from two different perspectives.
The TAG review of Covaxin is expected this week.
Also read p10
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.